Papers from every journal, all in one place。 カスタムフィードを作成できます。
Randomized trial compares immediate and deferred PCI outcomes in myocardial infarction patients, indicating potential timing benefits.

Professor of Cardiovascular Imaging, Radboud University Medical Center, Radboud University Medical Center
These guidelines were based on two major studies that showed a small short-term benefit to immediate treatment, but not in the long term. Our study provides more clarity: that benefit doesn't actually exist.
Randomized trial examines the effects of stopping beta-blockers on mortality after myocardial infarction, suggesting important implications.

Cardiologist, Samsung Medical Center, Seoul, Samsung Medical Center
The SMART-DECISION trial is the first randomized study to demonstrate the noninferiority of beta-blocker discontinuation in post-MI patients without left ventricular systolic dysfunction or heart failure.
Randomized trial reveals improved cardiac rhythm outcomes in patients with persistent atrial fibrillation, indicating effective treatment strategies.

Cardiologist, Vancouver General Hospital
Traditionally, we've taken a stepwise approach, starting with medications and moving to procedures later. What this trial shows is that, even in patients with more advanced AFib, earlier intervention with ablation can provide substantial benefits and better control of the disease.
Supports testing access interventions in low-income hypertension care; leaves open scalability and outcome impact in broader trials.

Chair of Epidemiology, UT Southwestern Medical Center, UT Southwestern Medical Center
Poor hypertension control is a major clinical and public health challenge. This effective, sustainable, and scalable implementation strategy should be widely adopted in the U.S. to improve hypertension control.
May support physiological assessment in coronary disease; hypothesis-generating and requires larger trials before practice change.
